Report Detail

Request for Sample of this report

Pharma & Healthcare Global Platinum-based Antineoplastic Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4624669
    • |
  • 10 September, 2025
    • |
  • Global
    • |
  • 106 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Platinum-based Antineoplastic market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
A kind of chemotherapy medication
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Platinum-based Antineoplastic market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Platinum-based Antineoplastic market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
Global Platinum-based Antineoplastic market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
Global Platinum-based Antineoplastic market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
Global Platinum-based Antineoplastic market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Platinum-based Antineoplastic
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Platinum-based Antineoplastic market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, AstraZeneca, Roche, Sanofi, Bristol-Myers Squibb, Asta Medica GmbH, Simcere Pharmaceutical, Abbvie, Novartis, GSK, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Platinum-based Antineoplastic market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Cisplatin
Carboplatin
Nedaplatin
Oxaliplatin
Lobaplatin
Cycloplatin
Market segment by Application
Combination Therapy
Monotherapy
Targeted Therapy
Major players covered
Pfizer
AstraZeneca
Roche
Sanofi
Bristol-Myers Squibb
Asta Medica GmbH
Simcere Pharmaceutical
Abbvie
Novartis
GSK
MSD
Hengrui Medicine
Hansoh Pharmaceutical Group
ChiTaiTianQing Pharmaceutical Group
CSPC Pharmaceutical Group
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Platinum-based Antineoplastic product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Platinum-based Antineoplastic, with price, sales quantity, revenue, and global market share of Platinum-based Antineoplastic from 2020 to 2025.
Chapter 3, the Platinum-based Antineoplastic competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Platinum-based Antineoplastic breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Platinum-based Antineoplastic market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Platinum-based Antineoplastic.
Chapter 14 and 15, to describe Platinum-based Antineoplastic sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Platinum-based Antineoplastic Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Cisplatin
    • 1.3.3 Carboplatin
    • 1.3.4 Nedaplatin
    • 1.3.5 Oxaliplatin
    • 1.3.6 Lobaplatin
    • 1.3.7 Cycloplatin
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Platinum-based Antineoplastic Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Combination Therapy
    • 1.4.3 Monotherapy
    • 1.4.4 Targeted Therapy
  • 1.5 Global Platinum-based Antineoplastic Market Size & Forecast
    • 1.5.1 Global Platinum-based Antineoplastic Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Platinum-based Antineoplastic Sales Quantity (2020-2031)
    • 1.5.3 Global Platinum-based Antineoplastic Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Pfizer
    • 2.1.1 Pfizer Details
    • 2.1.2 Pfizer Major Business
    • 2.1.3 Pfizer Platinum-based Antineoplastic Product and Services
    • 2.1.4 Pfizer Platinum-based Antineoplastic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Pfizer Recent Developments/Updates
  • 2.2 AstraZeneca
    • 2.2.1 AstraZeneca Details
    • 2.2.2 AstraZeneca Major Business
    • 2.2.3 AstraZeneca Platinum-based Antineoplastic Product and Services
    • 2.2.4 AstraZeneca Platinum-based Antineoplastic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 AstraZeneca Recent Developments/Updates
  • 2.3 Roche
    • 2.3.1 Roche Details
    • 2.3.2 Roche Major Business
    • 2.3.3 Roche Platinum-based Antineoplastic Product and Services
    • 2.3.4 Roche Platinum-based Antineoplastic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Roche Recent Developments/Updates
  • 2.4 Sanofi
    • 2.4.1 Sanofi Details
    • 2.4.2 Sanofi Major Business
    • 2.4.3 Sanofi Platinum-based Antineoplastic Product and Services
    • 2.4.4 Sanofi Platinum-based Antineoplastic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Sanofi Recent Developments/Updates
  • 2.5 Bristol-Myers Squibb
    • 2.5.1 Bristol-Myers Squibb Details
    • 2.5.2 Bristol-Myers Squibb Major Business
    • 2.5.3 Bristol-Myers Squibb Platinum-based Antineoplastic Product and Services
    • 2.5.4 Bristol-Myers Squibb Platinum-based Antineoplastic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Bristol-Myers Squibb Recent Developments/Updates
  • 2.6 Asta Medica GmbH
    • 2.6.1 Asta Medica GmbH Details
    • 2.6.2 Asta Medica GmbH Major Business
    • 2.6.3 Asta Medica GmbH Platinum-based Antineoplastic Product and Services
    • 2.6.4 Asta Medica GmbH Platinum-based Antineoplastic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Asta Medica GmbH Recent Developments/Updates
  • 2.7 Simcere Pharmaceutical
    • 2.7.1 Simcere Pharmaceutical Details
    • 2.7.2 Simcere Pharmaceutical Major Business
    • 2.7.3 Simcere Pharmaceutical Platinum-based Antineoplastic Product and Services
    • 2.7.4 Simcere Pharmaceutical Platinum-based Antineoplastic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Simcere Pharmaceutical Recent Developments/Updates
  • 2.8 Abbvie
    • 2.8.1 Abbvie Details
    • 2.8.2 Abbvie Major Business
    • 2.8.3 Abbvie Platinum-based Antineoplastic Product and Services
    • 2.8.4 Abbvie Platinum-based Antineoplastic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Abbvie Recent Developments/Updates
  • 2.9 Novartis
    • 2.9.1 Novartis Details
    • 2.9.2 Novartis Major Business
    • 2.9.3 Novartis Platinum-based Antineoplastic Product and Services
    • 2.9.4 Novartis Platinum-based Antineoplastic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Novartis Recent Developments/Updates
  • 2.10 GSK
    • 2.10.1 GSK Details
    • 2.10.2 GSK Major Business
    • 2.10.3 GSK Platinum-based Antineoplastic Product and Services
    • 2.10.4 GSK Platinum-based Antineoplastic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 GSK Recent Developments/Updates
  • 2.11 MSD
    • 2.11.1 MSD Details
    • 2.11.2 MSD Major Business
    • 2.11.3 MSD Platinum-based Antineoplastic Product and Services
    • 2.11.4 MSD Platinum-based Antineoplastic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 MSD Recent Developments/Updates
  • 2.12 Hengrui Medicine
    • 2.12.1 Hengrui Medicine Details
    • 2.12.2 Hengrui Medicine Major Business
    • 2.12.3 Hengrui Medicine Platinum-based Antineoplastic Product and Services
    • 2.12.4 Hengrui Medicine Platinum-based Antineoplastic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Hengrui Medicine Recent Developments/Updates
  • 2.13 Hansoh Pharmaceutical Group
    • 2.13.1 Hansoh Pharmaceutical Group Details
    • 2.13.2 Hansoh Pharmaceutical Group Major Business
    • 2.13.3 Hansoh Pharmaceutical Group Platinum-based Antineoplastic Product and Services
    • 2.13.4 Hansoh Pharmaceutical Group Platinum-based Antineoplastic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Hansoh Pharmaceutical Group Recent Developments/Updates
  • 2.14 ChiTaiTianQing Pharmaceutical Group
    • 2.14.1 ChiTaiTianQing Pharmaceutical Group Details
    • 2.14.2 ChiTaiTianQing Pharmaceutical Group Major Business
    • 2.14.3 ChiTaiTianQing Pharmaceutical Group Platinum-based Antineoplastic Product and Services
    • 2.14.4 ChiTaiTianQing Pharmaceutical Group Platinum-based Antineoplastic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 ChiTaiTianQing Pharmaceutical Group Recent Developments/Updates
  • 2.15 CSPC Pharmaceutical Group
    • 2.15.1 CSPC Pharmaceutical Group Details
    • 2.15.2 CSPC Pharmaceutical Group Major Business
    • 2.15.3 CSPC Pharmaceutical Group Platinum-based Antineoplastic Product and Services
    • 2.15.4 CSPC Pharmaceutical Group Platinum-based Antineoplastic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 CSPC Pharmaceutical Group Recent Developments/Updates

3 Competitive Environment: Platinum-based Antineoplastic by Manufacturer

  • 3.1 Global Platinum-based Antineoplastic Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Platinum-based Antineoplastic Revenue by Manufacturer (2020-2025)
  • 3.3 Global Platinum-based Antineoplastic Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Platinum-based Antineoplastic by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Platinum-based Antineoplastic Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Platinum-based Antineoplastic Manufacturer Market Share in 2024
  • 3.5 Platinum-based Antineoplastic Market: Overall Company Footprint Analysis
    • 3.5.1 Platinum-based Antineoplastic Market: Region Footprint
    • 3.5.2 Platinum-based Antineoplastic Market: Company Product Type Footprint
    • 3.5.3 Platinum-based Antineoplastic Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Platinum-based Antineoplastic Market Size by Region
    • 4.1.1 Global Platinum-based Antineoplastic Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Platinum-based Antineoplastic Consumption Value by Region (2020-2031)
    • 4.1.3 Global Platinum-based Antineoplastic Average Price by Region (2020-2031)
  • 4.2 North America Platinum-based Antineoplastic Consumption Value (2020-2031)
  • 4.3 Europe Platinum-based Antineoplastic Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Platinum-based Antineoplastic Consumption Value (2020-2031)
  • 4.5 South America Platinum-based Antineoplastic Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Platinum-based Antineoplastic Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Platinum-based Antineoplastic Sales Quantity by Type (2020-2031)
  • 5.2 Global Platinum-based Antineoplastic Consumption Value by Type (2020-2031)
  • 5.3 Global Platinum-based Antineoplastic Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Platinum-based Antineoplastic Sales Quantity by Application (2020-2031)
  • 6.2 Global Platinum-based Antineoplastic Consumption Value by Application (2020-2031)
  • 6.3 Global Platinum-based Antineoplastic Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Platinum-based Antineoplastic Sales Quantity by Type (2020-2031)
  • 7.2 North America Platinum-based Antineoplastic Sales Quantity by Application (2020-2031)
  • 7.3 North America Platinum-based Antineoplastic Market Size by Country
    • 7.3.1 North America Platinum-based Antineoplastic Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Platinum-based Antineoplastic Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Platinum-based Antineoplastic Sales Quantity by Type (2020-2031)
  • 8.2 Europe Platinum-based Antineoplastic Sales Quantity by Application (2020-2031)
  • 8.3 Europe Platinum-based Antineoplastic Market Size by Country
    • 8.3.1 Europe Platinum-based Antineoplastic Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Platinum-based Antineoplastic Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Platinum-based Antineoplastic Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Platinum-based Antineoplastic Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Platinum-based Antineoplastic Market Size by Region
    • 9.3.1 Asia-Pacific Platinum-based Antineoplastic Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Platinum-based Antineoplastic Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Platinum-based Antineoplastic Sales Quantity by Type (2020-2031)
  • 10.2 South America Platinum-based Antineoplastic Sales Quantity by Application (2020-2031)
  • 10.3 South America Platinum-based Antineoplastic Market Size by Country
    • 10.3.1 South America Platinum-based Antineoplastic Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Platinum-based Antineoplastic Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Platinum-based Antineoplastic Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Platinum-based Antineoplastic Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Platinum-based Antineoplastic Market Size by Country
    • 11.3.1 Middle East & Africa Platinum-based Antineoplastic Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Platinum-based Antineoplastic Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Platinum-based Antineoplastic Market Drivers
  • 12.2 Platinum-based Antineoplastic Market Restraints
  • 12.3 Platinum-based Antineoplastic Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Platinum-based Antineoplastic and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Platinum-based Antineoplastic
  • 13.3 Platinum-based Antineoplastic Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Platinum-based Antineoplastic Typical Distributors
  • 14.3 Platinum-based Antineoplastic Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Platinum-based Antineoplastic. Industry analysis & Market Report on Platinum-based Antineoplastic is a syndicated market report, published as Global Platinum-based Antineoplastic Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Platinum-based Antineoplastic market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo